Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.

Objective

The objective of this project was to advise our client on the sustained release concept for glucosamine and the best technologies to achieve it.

In addition the project was to investigate whether providing glucosamine in a sustained release form has physiological benefits or not, or even contraindications.

Method

To carry out this project, CPL initially began discussions with two slow release technology vendors. We also contacted several companies known to us that were involved in the controlled release aspects of micro-encapsulation for food ingredients. In addition, we identified one additional company claiming to manufacture and sell a sustained release form of glucosamine and obtained information on product, price and supply from them.

In order to address the scientific issues underlying the performance of glucosamine and the possible benefits of a sustained release product, we reviewed in detail the scientific, medical, clinical and patent literature concerning glucosamine and its use.

Click to see the contents of the study or look below for an outline.

Table of Contents

Objective

Method

Short Answers to Client’s Questions

Principal Findings

  • From An Overview of the Science and Clinical Trials
    • Is glucosamine effective?
    • Does glucosamine reduce pain or influence pain factors?
    • Does glucosamine provide protection of joint structure?
    • Does glucosamine being available in the bloodstream mean that it is delivered to the joints?
    • Is timed release better than three doses?
    • Toxicity – is glucosamine safe?
    • Is there a problem for diabetics?
    • Clinical trials
    • Other opinions
  • On The Various Sustained Release Systems
    • Company 1’s product
    • Company 2’s product
    • Company 3’s product
    • Others

Conclusions

  • On Glucosamine Performance, Form and Format
  • On The Various Sustained Release Systems
    • Company 1’s product
    • Company 2’s product
    • Company 3’s product
    • Others

Recommendations

Scientific Research

  • Introduction to the Disease Process of Osteoarthritis
  • Is Glucosamine Effective?
    • Research to Support
    • Maybe
    • Research that does not support
  • Does Glucosamine Reduce Pain or Influence Pain Factors?
    • Research to support
    • Maybe
    • Research that does not support
  • Does Glucosamine Provide Protection Of Joint Structure?
    • Research to Support
    • Research that does not support
  • Does Glucosamine Being Available in the Bloodstream Mean That it is Delivered to the Joints?
    • Research to Support
    • Research that does not support
  • Is Timed Release Better than Three Doses?
    • Research to support
    • Research that does not support
  • Toxicity – Is Glucosamine Safe?
    • General research to support safety
    • Research that does not support
  • Is There a Problem for Diabetics?
    • Research to support
    • Maybe
    • Research that does not support
  • What Clinical Trials Have Been Done or are Ongoing?
  • What Other Publications on Glucosamine Might be Relevant

Contacts

  • Academic and Medical
    • 10 contacts
  • Commercial
    • 5 contacts

Share this project: